Vascular Biogenics Ltd (NASDAQ:VBLT)

1.35
Delayed Data
As of Aug 05
 +0.04 / +3.08%
Today’s Change
0.90
Today|||52-Week Range
1.64
+12.50%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$62.7M

Company Description

Vascular Biogenics Ltd. is in the clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of first-in-class treatments for cancer. Its programs include cancer, inflammation, and VB-600 which are focused on treating tumors, ovarian cancer, and chronic immune-related indications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel.

Contact Information

Vascular Biogenics Ltd.
8 HaSatat Street
Modi’in Jerusalem 7178106
P:(728) 993-5000
Investor Relations:

Employees

Shareholders

Other institutional6.52%
Individual stakeholders10.14%
Mutual fund holders0.79%

Top Executives

Dror HaratsChief Executive Officer & Director
Eyal BreitbartVice President-Research & Operations
Erez FeigeVice President-Business Operations
Amos RonChief Financial Officer & Secretary
Tami RachmilewitzVice President-Clinical Development